CORV $2.19

0.17 (8.4%)

correvio.com

CORV Profile

SECTOR
Health Care
MARKET CAPITALIZATION
110 Million
Correvio Pharma Corp is specialty pharmaceutical company. It offers patients and healthcare providers therapeutic solutions for acute medical conditions to improve health and quality of life. Its products are Aggrastat, Esmocard, Brinavess, Xydalba, Zevtera/Mabelio, and others. It offers solutions on Acute Bacterial Skin and Skin Structure Infections, Acute Coronary Syndromes, Atrial Fibrillation, Hospital Acquired Pneumonia & Community Acquired Pneumonia, Pulmonary Arterial Hypertension, and Supraventricular Tachycardia. The firm earns revenue from the sale of company's commercialized products. It has Europe and Rest of the world geographic segments.

CORV Earnings

EPS -0.23
P/E Ratio --
Previous Wed, Aug 14, 2019
Latest Thu, Nov 14, 2019 (21 days ago) Price -0.45%

CORV Dividend

--
Ex-Date --
Pay Date --
History --

CORV Charts

All Time High $72.25 Tue, Jan 31, 2006


Drug Manufacturers Industry Stocks
NVS 91.73 0.17 0.19%
AZN 47.66 0.54 -1.12%
GSK 45.02 0.05 -0.11%
ELAN 27.07 0.10 -0.37%
BHC 28.71 0.03 0.10%
CTLT 51.47 0.31 -0.60%
MDCO 84.01 0.06 -0.07%
RDY 40.08 0.12 -0.30%
CGC 18.51 0.13 0.71%
HZNP 31.91 0.71 -2.18%
Symbol Price Day YTD
CORV $2.19 8.4% -10.3%


Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com



    TOP    

©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy Terms Of Service Privacy Policy